Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Asian Medical Markets Expert to Attend the MD & M Midwest Conference

September 23, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

BETHESDA, Md., Sept. 23 /- Pacific Bridge Medical will be attending the Medical Design and Manufacturing (MD&M) Midwest Conference from September 28-30, 2010, at the Donald E. Stephens Convention Center in Rosemont, Illinois. MD&M Midwest is part of a national conference series...

TOPICS:

Corgenix Reports Fiscal 2010 Financial Results

September 23, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

DENVER, Sept. 23 /- Corgenix Medical Corporation (OTC Bulletin Board: CONX ), a worldwide developer and marketer of diagnostic test kits, today filed its fiscal year Form 10-K and reported financial results. The report disclosed that the company's operating results have advanced for the...

TOPICS:

Mayo Clinic Research on SurgiCount To Be Presented at Conferences

September 23, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

TEMECULA, Calif., Sept. 23 /- SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. (OTC Bulletin Board: PSTX ), announced that results of independent, unsponsored clinical research conducted by the Mayo Clinic on their multi-year effort to reduce...

TOPICS:
Advertisement

Latin American Aortic Stent Graft Market to Reach Over $150 Million by 2015, According to Millennium Research Group

September 23, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

TORONTO, Sept. 23 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Latin American physicians will increasingly adopt abdominal and thoracic endovascular aortic repair in place of surgical repair through 2015 as awareness of...

TOPICS:

The New Face of Body Contouring

September 23, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

LOUISVILLE, Colo., Sept. 23 /- As technologies for fat removal become more advanced, physicians now have a superior choice in not only reshaping the body but also recycling the fat to further enhance appearance. According to the most recent statistics from the American Society for...

TOPICS:

Beardsworth® Selects OmniComm Systems® AE Reporting System

September 23, 2010 6:31 am | by Bio-Medicine.Org | News | Comments

FORT LAUDERDALE, Fla., Sept. 23 /- OmniComm Systems, Inc. (OTC: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that Beardsworth, a full service contract research organization (CRO) who specializes in difficult therapeutic areas, has selected OmniComm's...

TOPICS:

Fittings Product Line Expanded With Polycarbonate Offerings

September 23, 2010 6:31 am | Colder Products Company | Product Releases | Comments

The latest additions include hose barb to hose barb tees, straights, elbows, and Ys, along with luers, all in medical-grade polycarbonate material.

Contact System Has Integrated Isolation Seals

September 23, 2010 6:22 am | Bal Seal Engineering, Inc. | Product Releases | Comments

Bal Seal Engineering Inc., a global provider of custom-engineered sealing, connecting, and conducting solutions, has announced plans to launch the world’s first integrated seal and electrical contact system for active implantable devices.

TOPICS:
Advertisement

ENTrigue Surgical, Inc. Announces Initial Clinical Experience with Ventera™ Sinus Dilation Systems and the Commercial Launch of Synaero™ Hemostasis Product

September 23, 2010 5:25 am | News | Comments

SAN ANTONIO, Sept. 23 /PRNewswire/ -- ENTrigue Surgical, Inc. ("ENTrigue"), a San Antonio, Texas-based company that designs, develops, manufactures and distributes medical devices used for Ear, Nose and Throat surgical procedures, announced today the first clinical experience with its Ventera™ sinus dilation systems.

TOPICS:

Covidien raises quarterly dividend to 20 cents

September 23, 2010 4:45 am | by The Associated Press | News | Comments

Drug and medical device maker Covidien PLC said Thursday it is raising its quarterly dividend by 11 percent to 20 cents from 18 cents.The Irish company is also boosting its annual dividend rate to 80 cents from 72 cents.Covidien said the dividend is payable Nov. 8 to shareholders of record on...

Surefil Emerges from Chapter 11

September 23, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

GRAND RAPIDS, Mich., Sept. 23 /- Surefil, a contract manufacturer of liquid-fill products for the personal care, home care, oral care, medical industries, and energy drinks, emerged from Chapter 11 protection with Federal Court approval on September 15, 2010. The company was able to...

TOPICS:

GSMA's Global Mobile Awards To Recognise Mobile Innovation in the mHealth Sector

September 23, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

LONDON, Sept. 23 /- The GSMA, which represents the interests of the worldwide mobile communications industry, has launched its prestigious 16th Annual Global Mobile Awards programme. New categories have been added to recognise excellence, achievement and innovation in the broad and...

TOPICS:

Ultrasonix Announces New Digital Ultrasound Exam Recording Technology

September 23, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

RICHMOND, British Columbia, Sept. 23 /- Ultrasonix Medical Corporation, a leading developer and manufacturer of high quality diagnostic ultrasound imaging systems is pleased to announce today the introduction of SonixVCR, a software-based innovation that records, stores, and exports...

TOPICS:

DuPont and DSM Announce Joint Venture in Surgical Biomedical Materials

September 23, 2010 1:33 am | by Bio-Medicine.Org | News | Comments

WILMINGTON, Del., and HEERLEN, Netherlands, Sept. 23 /- DuPont (NYSE: DD ) and Royal DSM N.V. announce an agreement to form a joint venture to develop, manufacture and commercialize advanced surgical biomedical materials, pending European Union regulatory approval. The joint venture will...

TOPICS:

US and EU Regulatory Submissions for Vandetanib in Advanced Medullary Thyroid Cancer Accepted for Review

September 23, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

LONDON, Sept. 23 /- AstraZeneca today announced that the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib in the treatment of patients with advanced medullary thyroid cancer...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading